SEC Form D · filed August 9, 2024
Enlaza Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Sanford Madigan · La Jolla, CAExecStephen Squinto · La Jolla, CADirectorShelley Chu · La Jolla, CADirectorTighe Reardon · La Jolla, CAExecJay Lichter · La Jolla, CADirectorMarcos Milla · La Jolla, CADirectorJames N. Topper · La Jolla, CADirectorSergio Duron · La Jolla, CAExec · DirectorByron M. Smith · Nashville, TNExecRegan Bozman · San Francisco, CAExec · DirectorChristopher Rand · Nashville, TNDirectorBrian M. Laden · Nashville, TNDirectorMark S. Rosen · Morristown, NJDirectorGerard M. Hayden, Jr · Nashville, TNExecStephen Squinto · La Jolla, CADirectorTyler M. Whitmore · Nashville, TNDirectorMarc Chalfin · Miami Beach, FLExec · DirectorTheodore Woo · Miami Beach, FLExecMarc Chalfin · Miami Beach, FLExecEric C. Harweger · Ames, IADirectorDavid R. Phaup · Edwardsville, ILDirectorBruce E. Schneider · Venedy, ILDirectorMike D. Christensen · Edwardsville, ILDirectorVontobel Asset Management, Inc · NEW YORK, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗